Skip to main content

MI - Use of Beta Blocker Therapy

CBE ID
0613e
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

The percentage of patients aged 18 years and older diagnosed with myocardial infarction (MI) who are taking a beta blocker

    Measure Specs
      General Information
      1.14 Numerator

      Patients with a current fill for beta blocker therapy

      1.15 Denominator

      All patients aged 18 and older diagnosed with myocardial infarction (MI) anytime in the past

      Exclusions

      Contraindications to a beta blocker, including:
      • Asthma
      • COPD
      • Bradycardia
      • Hypotension
      • Aortic stenosis
      • Peripheral artery disease medications
      • Heart block
      • Heart transplant

      General exclusions:
      • Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
      • Patients who have been in a skilled nursing facility in the last 3 months
      • Patient or provider feedback indicating allergy or intolerance to the drug in the past
      • Patient or provider feedback indicating that there is a contraindication to adding the drug

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      ActiveHealth Management
      Steward POC email
      mvemireddy@activehealth.net
                Public Comments